Through multifaceted analyses including protein profiling, cellular subpopulation distribution, and receptor-ligand interactions, we identified key features of tumor remodeling of the peripheral immune system, mainly in the form of enhanced inflammation and changes in CD4+T cell function. Here, CD4 is linked to neoplasm.